Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elinzanetant pharmacokinetics with esomeprazole and IV microtracer
NL-OMON50454Active, not recruiting
- Sponsor
- Bayer
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of elinzanetant and esomeprazole in vasomotor symptoms, sponsored by Bayer. Primary endpoint: Effect of multiple doses of esomeprazole on the pharmacokinetics of elinzanetant. Started Sep 2021; status: active, not recruiting.
02
Drugs
elinzanetantesomeprazole
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NL-OMON50454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50454.